- Leaked internal emails appear to show employees at one of the world’s leading pharmaceutical companies calling for “celebration” over price hikes of cancer drugs, an investigation has revealed.
- After purchasing five different cancer drugs from British firm GlaxoSmithKline (GSK), the company tried to sell the medicines in Europe for up to 40 times their previous price, reported The Times.
- Price rises for generic cancer drugs, such as those acquired by Aspen, cost the NHS in England around £380m a year for prescriptions dispensed outside hospitals, the European Cancer Congress has estimated.
- When bargaining over drug prices in Spain, the pharmaceutical giant is said to have threatened to stop selling the cancer treatments unless the health minister agreed to price rises of up to 4,000 per cent, reported Spanish online newspaper El Confidencial Digital at the time.
- The Department of Health has said it plans to cut generic drug costs after researchers said there has been a sharp increase in the price of cancer drugs in the last five years, leading to their use being restricted in the NHS.
@aral: “Next time you hear “self regulation”, consider: Pharma giant “plotted to destroy cancer drugs to drive prices up”” open tweet »